These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 2523688)

  • 1. New macrolides active against Streptococcus pyogenes with inducible or constitutive type of macrolide-lincosamide-streptogramin B resistance.
    Fernandes PB; Baker WR; Freiberg LA; Hardy DJ; McDonald EJ
    Antimicrob Agents Chemother; 1989 Jan; 33(1):78-81. PubMed ID: 2523688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains.
    Giovanetti E; Montanari MP; Mingoia M; Varaldo PE
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1935-40. PubMed ID: 10428916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors.
    Bemer-Melchior P; Juvin ME; Tassin S; Bryskier A; Schito GC; Drugeon HB
    Antimicrob Agents Chemother; 2000 Nov; 44(11):2999-3002. PubMed ID: 11036012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrolide-lincosamide-streptogramin B (MLS) resistance in cutaneous propionibacteria: definition of phenotypes.
    Eady EA; Ross JI; Cove JH; Holland KT; Cunliffe WJ
    J Antimicrob Chemother; 1989 Apr; 23(4):493-502. PubMed ID: 2501269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolide, lincosamide and streptogramin resistance in Campylobacter jejuni/coli.
    Burridge R; Warren C; Phillips I
    J Antimicrob Chemother; 1986 Mar; 17(3):315-21. PubMed ID: 3084440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.
    Sutcliffe J; Tait-Kamradt A; Wondrack L
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1817-24. PubMed ID: 8843287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues.
    Elliott RL; Pireh D; Griesgraber G; Nilius AM; Ewing PJ; Bui MH; Raney PM; Flamm RK; Kim K; Henry RF; Chu DT; Plattner JJ; Or YS
    J Med Chem; 1998 May; 41(10):1651-9. PubMed ID: 9572890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area.
    Hasenbein ME; Warner JE; Lambert KG; Cole SE; Onderdonk AB; McAdam AJ
    J Clin Microbiol; 2004 Apr; 42(4):1559-63. PubMed ID: 15071004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain.
    Portillo A; Lantero M; Gastañares MJ; Ruiz-Larrea F; Torres C
    Int J Antimicrob Agents; 1999 Oct; 13(2):137-40. PubMed ID: 10595574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999.
    Schlegel L; Merad B; Rostane H; Broc V; Bouvet A
    Clin Microbiol Infect; 2001 Jul; 7(7):362-6. PubMed ID: 11531981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to macrolide-lincosamide-streptogramin antibiotics in enterococci from the intestines of animals.
    Dutta GN; Devriese LA
    Res Vet Sci; 1982 Jul; 33(1):70-2. PubMed ID: 6813931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growth.
    Goldman RC; Kadam SK
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1058-66. PubMed ID: 2506804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of macrolide-lincosamide-streptogramin resistances among staphylococcal clinical isolates at a university medical center. Is false susceptibility to new macrolides and clindamycin a contemporary clinical and in vitro testing problem?
    Sanchez ML; Flint KK; Jones RN
    Diagn Microbiol Infect Dis; 1993; 16(3):205-13. PubMed ID: 8477574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A family of r-determinants in Streptomyces spp. that specifies inducible resistance to macrolide, lincosamide, and streptogramin type B antibiotics.
    Fujisawa Y; Weisblum B
    J Bacteriol; 1981 May; 146(2):621-31. PubMed ID: 6163765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide resistance in Peptostreptococcus spp. mediated by ermTR: possible source of macrolide-lincosamide-streptogramin B resistance in Streptococcus pyogenes.
    Reig M; Galan J; Baquero F; Perez-Diaz JC
    Antimicrob Agents Chemother; 2001 Feb; 45(2):630-2. PubMed ID: 11158770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro.
    Van Asselt GJ; Sloos JH; Mouton RP; Van Boven CP; Van de Klundert JA
    J Med Microbiol; 1995 Nov; 43(5):386-91. PubMed ID: 7563004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides.
    Hardy DJ; Hensey DM; Beyer JM; Vojtko C; McDonald EJ; Fernandes PB
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1710-9. PubMed ID: 3252753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics.
    Leclercq R; Nantas L; Soussy CJ; Duval J
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():67-75. PubMed ID: 1399953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues.
    Griesgraber G; Kramer MJ; Elliott RL; Nilius AM; Ewing PJ; Raney PM; Bui MH; Flamm RK; Chu DT; Plattner JJ; Or YS
    J Med Chem; 1998 May; 41(10):1660-70. PubMed ID: 9572891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.